id,disease_progression_status,survival_status,clinical_response_rate_target_lasion,clinical_response_rate_non_target_lasion,clinical_response_rate_new_lasion,clinical_response_rate_result,radiological_response_rate_target_lasion,radiological_response_rate_non_target_lasion,radiological_response_rate_new_lasion,radiological_response_rate_result,pathological_response_rate_target_lasion,pathological_response_rate_non_target_lasion,pathological_response_rate_new_lasion,pathological_response_rate_result,time,registration_number,laterality,current_chemo_protocol,chemo_starting_date,chemo_cycle_no,chemo_detail,disease_progression_status_date,pfs,survival_status_date,overall_survival,clinical_response_rate_date,radiological_response_rate_date,pathological_response_rate_date,cancer_type,patient_id_id,patient_id_socio_economic_status_name,patient_id_unique_id,patient_id_name,patient_id_phone,patient_id_date_of_birth,patient_id_gender,patient_id_blood_group,patient_id_area,patient_id_police_station,patient_id_district,doctor_id_name,center_id_name,grade_name,line_of_treatment_name,diagnosis_disease_group_name,diagnosis_subgroup_diagnosis_disease_group_name,diagnosis_subgroup_name,diagnosis_primary_site_name,diagnosis_laterility_name,patient_id_socio_economic_status,grade,disease_progression_status_name,survival_status_name,clinical_response_rate_target_lasion_name,clinical_response_rate_non_target_lasion_name,clinical_response_rate_new_lasion_name,clinical_response_rate_result_name,radiological_response_rate_target_lasion_name,radiological_response_rate_non_target_lasion_name,radiological_response_rate_new_lasion_name,radiological_response_rate_result_name,diagnosis_laterility,line_of_treatment,diagnosis_subgroup,pathological_response_rate_target_lasion_name,pathological_response_rate_non_target_lasion_name,pathological_response_rate_new_lasion_name,pathological_response_rate_result_name,diagnosis_disease_group,diagnosis_primary_site,name,value,unit,date,patient_observation_id
840,,,,,,,,,,,,,,,2024-07-09T21:43:27+06:00,BSH - ,Left,,,,"NACT Cycle 1 with AC from 20.02.21> Cycle 4 with AC completed on 24.04.21>
Pacli+carboplatin 4 cycle completed on 30.08.21> Received 8 cycle Capecitabine upto June, 2022",2023-11-08,,2023-11-08,,2023-10-01,2023-10-01,2023-10-01,Breast,123,Upper middle class,BSBSC-240000123,NILUFAR IBRAHIM,1768964422,1958-11-24,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,2.0,,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.3- Lower-inner quadrant of breast,Breast,Left,,,Stable,Alive,CR,,,,CR,,,,,,,CR,,,,,,CA15.3,9.8,,2021-02-11,840.0
840,,,,,,,,,,,,,,,2024-07-09T21:43:27+06:00,BSH - ,Left,,,,"NACT Cycle 1 with AC from 20.02.21> Cycle 4 with AC completed on 24.04.21>
Pacli+carboplatin 4 cycle completed on 30.08.21> Received 8 cycle Capecitabine upto June, 2022",2023-11-08,,2023-11-08,,2023-10-01,2023-10-01,2023-10-01,Breast,123,Upper middle class,BSBSC-240000123,NILUFAR IBRAHIM,1768964422,1958-11-24,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,2.0,,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.3- Lower-inner quadrant of breast,Breast,Left,,,Stable,Alive,CR,,,,CR,,,,,,,CR,,,,,,CA15.3,11.5,,2021-05-18,840.0
840,,,,,,,,,,,,,,,2024-07-09T21:43:27+06:00,BSH - ,Left,,,,"NACT Cycle 1 with AC from 20.02.21> Cycle 4 with AC completed on 24.04.21>
Pacli+carboplatin 4 cycle completed on 30.08.21> Received 8 cycle Capecitabine upto June, 2022",2023-11-08,,2023-11-08,,2023-10-01,2023-10-01,2023-10-01,Breast,123,Upper middle class,BSBSC-240000123,NILUFAR IBRAHIM,1768964422,1958-11-24,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,2.0,,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.3- Lower-inner quadrant of breast,Breast,Left,,,Stable,Alive,CR,,,,CR,,,,,,,CR,,,,,,CA15.3,12.6,,2021-08-17,840.0
840,,,,,,,,,,,,,,,2024-07-09T21:43:27+06:00,BSH - ,Left,,,,"NACT Cycle 1 with AC from 20.02.21> Cycle 4 with AC completed on 24.04.21>
Pacli+carboplatin 4 cycle completed on 30.08.21> Received 8 cycle Capecitabine upto June, 2022",2023-11-08,,2023-11-08,,2023-10-01,2023-10-01,2023-10-01,Breast,123,Upper middle class,BSBSC-240000123,NILUFAR IBRAHIM,1768964422,1958-11-24,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,2.0,,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.3- Lower-inner quadrant of breast,Breast,Left,,,Stable,Alive,CR,,,,CR,,,,,,,CR,,,,,,CA15.3,13.3,,2022-06-15,840.0
840,,,,,,,,,,,,,,,2024-07-09T21:43:27+06:00,BSH - ,Left,,,,"NACT Cycle 1 with AC from 20.02.21> Cycle 4 with AC completed on 24.04.21>
Pacli+carboplatin 4 cycle completed on 30.08.21> Received 8 cycle Capecitabine upto June, 2022",2023-11-08,,2023-11-08,,2023-10-01,2023-10-01,2023-10-01,Breast,123,Upper middle class,BSBSC-240000123,NILUFAR IBRAHIM,1768964422,1958-11-24,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,2.0,,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.3- Lower-inner quadrant of breast,Breast,Left,,,Stable,Alive,CR,,,,CR,,,,,,,CR,,,,,,CA15.3,13.6,,2023-01-12,840.0
840,,,,,,,,,,,,,,,2024-07-09T21:43:27+06:00,BSH - ,Left,,,,"NACT Cycle 1 with AC from 20.02.21> Cycle 4 with AC completed on 24.04.21>
Pacli+carboplatin 4 cycle completed on 30.08.21> Received 8 cycle Capecitabine upto June, 2022",2023-11-08,,2023-11-08,,2023-10-01,2023-10-01,2023-10-01,Breast,123,Upper middle class,BSBSC-240000123,NILUFAR IBRAHIM,1768964422,1958-11-24,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,2.0,,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.3- Lower-inner quadrant of breast,Breast,Left,,,Stable,Alive,CR,,,,CR,,,,,,,CR,,,,,,CA15.3,7.7,,2023-05-18,840.0
840,,,,,,,,,,,,,,,2024-07-09T21:43:27+06:00,BSH - ,Left,,,,"NACT Cycle 1 with AC from 20.02.21> Cycle 4 with AC completed on 24.04.21>
Pacli+carboplatin 4 cycle completed on 30.08.21> Received 8 cycle Capecitabine upto June, 2022",2023-11-08,,2023-11-08,,2023-10-01,2023-10-01,2023-10-01,Breast,123,Upper middle class,BSBSC-240000123,NILUFAR IBRAHIM,1768964422,1958-11-24,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,2.0,,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.3- Lower-inner quadrant of breast,Breast,Left,,,Stable,Alive,CR,,,,CR,,,,,,,CR,,,,,,CA15.3,9.8,,2023-11-06,840.0
127,,,,,,,,,,,,,,,2024-06-01T11:12:15+06:00,BSH - H12102142131,Left,,,,"NACT Cycle 1 with AC from 20.02.21> Cycle 4 with AC completed on 24.04.21>
Pacli+carboplatin 4 cycle completed on 30.08.21> Received 8 cycle Capecitabine upto June, 2022",2023-11-08,,2023-11-08,,2023-10-01,2023-10-01,2023-10-01,Breast,123,Upper middle class,BSBSC-240000123,NILUFAR IBRAHIM,1768964422,1958-11-24,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,2.0,,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.3- Lower-inner quadrant of breast,Breast,Left,,,Stable,Alive,CR,,,,CR,,,,,,,CR,,,,,,,,,,
723,,,,,,,,,,,,,,,2024-07-09T21:43:27+06:00,BSH - H12102142131,Left,,,,"NACT Cycle 1 with AC from 20.02.21> Cycle 4 with AC completed on 24.04.21>
Pacli+carboplatin 4 cycle completed on 30.08.21> Received 8 cycle Capecitabine upto June, 2022",2023-11-08,,2023-11-08,,2023-10-01,2023-10-01,2023-10-01,Breast,123,Upper middle class,BSBSC-240000123,NILUFAR IBRAHIM,1768964422,1958-11-24,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,2.0,,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.3- Lower-inner quadrant of breast,Breast,Left,,,Stable,Alive,CR,,,,CR,,,,,,,CR,,,,,,,,,,
724,,,,,,,,,,,,,,,2024-07-09T21:43:27+06:00,BSH - H12102142131,Left,,,,"NACT Cycle 1 with AC from 20.02.21> Cycle 4 with AC completed on 24.04.21>
Pacli+carboplatin 4 cycle completed on 30.08.21> Received 8 cycle Capecitabine upto June, 2022",2023-11-08,,2023-11-08,,2023-10-01,2023-10-01,2023-10-01,Breast,123,Upper middle class,BSBSC-240000123,NILUFAR IBRAHIM,1768964422,1958-11-24,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,2.0,,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.3- Lower-inner quadrant of breast,Breast,Left,,,Stable,Alive,CR,,,,CR,,,,,,,CR,,,,,,,,,,
